6 TECH OUTLOOKDecember - 2019EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comBioanalytical services are available for every phase of drug development, from discovery to clinical development phases. Various bioanalytical platforms are used to perform these services ranging from ligand binding assays, immunoassays, LC/MS, gas chromatography, cell-based assays, and mass spectrometry, among others. There is an ever-increasing demand for bioanalytical services in the biotechnology and pharmaceutical industry. Comparatively longer time duration and higher costs required to conduct bioanalytical services in-house is a significant factor driving demand for bioanalytical services. This has led to biotechnology and pharmaceutical companies outsourcing bioanalytical services to companies specializing in the domain. Moreover, an increase in the incidence of chronic diseases and a rise in the economic cost burden of these diseases on health care systems across the world are propelling the need for new and personalized medicine and innovative drugs to be introduced in the market. This has led to an increase in investment by biopharmaceutical companies in drug development and R&D, leading to higher demand for bioanalytical services in the global market. In conjunction with changing standards, companies must remain abreast of regulatory updates and use of expertise and advisory services. With an increasing number of players operating in the bioanalytical services market offering an end-to-end and diversified portfolio of bioanalytical services, these are the factors that fuel the growth of the global bioanalytical services market. Additionally, the economic benefits received from outsourcing instead of conducting an in-house study will augment the demand for bioanalytical testing services soon, enhancing the market growth in the process. As a prelude to the innumerable possibilities that bioanalytical services have to offer, in this edition of Pharma Tech Outlook, we present to you a list of companies that are transforming the bioanalytical services landscape with cutting edge technologies. We hope this edition will provide you with the right assistance in choosing the best-in-class service for your requirements.Do let us know your thoughts.Rise of Cost-Effective Bioanalytical ServicesCopyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 23 - 2019, Vol 05 - Issue 20 (ISSN 2644-2787 )Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerGeorge MathewEditorial StaffAaron Pierce Ava GarciaJenna VegasJoshua ParkerJustin SmithPaul BarberSalesRichard Watsonrichard@pharmatechoutlook.comPhone: 510.996.5173sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >